Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1312839 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1932599 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1318828 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL3793621 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL3795488 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1311334 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1931400 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL3799758 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1932997 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL8519807 | 1.00 | TSHR (0.47) | TSHRTHRBLMNADNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11628131-B2 | Ammonia-free bleaching kit for gentle brightening of keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2023-04-18 | — | — | US | claimed |
| US-20210169762-A1 | AMMONIA-FREE BLEACHING KIT FOR GENTLE BRIGHTENING OF KERATINOUS FIBERS | HENKEL AG & CO. KGAA (DE) | 2021-06-10 | — | — | US | claimed |
| US-20210169755-A1 | DUST REDUCED AMMONIUM FREE BLONDING POWDER | HENKEL AG & CO. KGAA (DE) | 2021-06-10 | — | — | US | claimed |
| EP-4683610-A1 | CATECHOL DERIVATIVES FOR TREATMENT OF SIGNS OF HAIR AGING AND/OR SCALP AGING | Henkel AG & Co. KGaA (DE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4673228-A1 | GEL HAVING IMPROVED USAGE PROPERTIES, FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS | Henkel AG & Co. KGaA (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4514306-A1 | OXIDATIVE HAIR-LIGHTENING AGENTS HAVING IMPROVED APPLICATION PROPERTIES FOR BLEACHING HAIR ROOTS | Henkel AG & Co. KGaA (DE) | 2025-03-05 | — | — | EP | disclosed |
| EP-4504133-A1 | ANTIDANDRUFF SHAMPOO | Henkel AG & Co. KGaA (DE) | 2025-02-12 | — | — | EP | disclosed |
| EP-4504135-A1 | HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION | Henkel AG & Co. KGaA (DE) | 2025-02-12 | — | — | EP | disclosed |
| EP-4475813-A1 | OXIDATIVE HAIR TREATMENT AGENT WITH A CONTROLLED HEAT DEVELOPMENT BASED ON ENVIRONMENTALLY FRIENDLY CONTENTS | Henkel AG & Co. KGaA (DE) | 2024-12-18 | — | — | EP | disclosed |
| EP-3082959-B2 | COSMETIC HAIR CLEANSING COMPOSITION | HENKEL AG & CO KGAA (DE) | 2024-12-04 | — | — | EP | disclosed |
| EP-4469017-A1 | PROCESS FOR TREATING KERATINOUS MATERIAL, COMPRISING THE MIXING OF AT LEAST TWO AGENTS (A) AND (B) | Henkel AG & Co. KGaA (DE) | 2024-12-04 | — | — | EP | disclosed |
| US-20050039271-A1 | Colouring agents | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-02-24 | — | — | US | disclosed |
| WO-2005013931-A1 | USE OF HALOGENATED HYDROXYDIPHENYL ETHER COMPOUNDS FOR THE TREATMENT OF THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-02-17 | — | — | WO | disclosed |
| US-20040208837-A1 | Agents and method for treating keratinous fibers | KRUEGER MARCUS (DE) | 2004-10-21 | — | — | US | disclosed |
| US-6730290-B2 | MIXTURE CONTAINING WAX, EMULSIFIERS AND PROPELLANTS | HANS SCHWARZKOPF GMBH & CO. KG (DE) | 2004-05-04 | — | — | US | disclosed |
| US-20040064901-A1 | Enzymatic coloring agents | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-04-08 | — | — | US | disclosed |
| EP-1378231-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | Ciba Specialty Chemicals Holding Inc. (CH) | 2004-01-07 | — | — | EP | disclosed |
| US-20030235540-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | CIBA SPECIALTY CHEMICALS CORP. | 2003-12-25 | — | — | US | disclosed |
| US-6648925-B1 | Including clathrate compounds having organometalic complex containing cavities | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2003-11-18 | — | — | US | disclosed |
| US-20030118516-A1 | Aerosol spray | HENKEL AG & CO. KGAA (DE) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050039271-A1 | Colouring agents | KRT18, CKMT1A; CKMT1B, CUTA | TSHR 4042/4885THRB 4443/4885LMNA 198/4885 |
| US-20030235540-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | CUTA, LIPC, AUP1 | TSHR 3689/4885THRB 4567/4885LMNA 770/4885 |
| US-20040064901-A1 | Enzymatic coloring agents | GLA, HEXA, HSD17B14 | TSHR 4375/4885THRB 4456/4885LMNA 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.